EORTC protocol 20995

Treatment of mantle cell lymphomas at advanced stages: prospective randomized comparison of myeloabative radiochemotherapy followed by blood stem cell transplantation versus maintenance with interferon alpha in first remission after initial cytoreductive chemotherapy with an anthracycline containing combination. A European Intergroup Trial.
Trial StatusClosed for recruitment
DatesDate of activation: 19-Feb-01
Closed on : 26-Oct-01
Data management at EORTCFull
Phase3
Randomized trialYes
TypeBone marrow trans
Targeted Sample size210
Number of steps1
Drug
Study StaffJ. C. Kluin-Nelemans (Study Coordinator) - University Medical Center Groningen, Groningen
Type of cancerNon Hodgkins Lymphoma
Participating GroupsGerman Low Grade Lymphoma Study Group(Coordinating Group)
EORTC Lymphoma Group
Groupe d'Etudes des Lymphomes de l'Adulte
Italian Lymphoma Group
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00016887
EudraCT
Back to Protocol section